SCHEMBL663906

SCHEMBL663906

CC(C(=O)O)c1ccccc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCL8 P10145 2/20 0.63
PTGS2 P35354 4/20 0.47
MMP1 P03956 1/20 0.46
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
MMP8 P22894 1/20 0.46
MMP12 P39900 1/20 0.46
MMP13 P45452 1/20 0.46
MMP14 P50281 1/20 0.46
MMP16 P51512 1/20 0.46
ACP3 P15309 1/20 0.46
GLS O94925 3/20 0.46
AKR1C3 P42330 1/20 0.45
AKR1C2 P52895 1/20 0.45
PTGS1 P23219 2/20 0.45
ADRB2 P07550 1/20 0.44
ADRB1 P08588 1/20 0.44
ALDH1A1 P00352 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29718684 1.00 CXCL8 (0.63) CXCL8PTGS2MMP1MMP2MMP9
SCHEMBL5672222 1.00 CXCL8 (0.63) CXCL8PTGS2MMP1MMP2MMP9
SCHEMBL4659044 1.00 CXCL8 (0.63) CXCL8PTGS2MMP1MMP2MMP9
SCHEMBL15695552 0.88 CXCL8 (0.50) CXCL8ACP3GLSADRB2ADRB1
SCHEMBL16798960 0.88 CXCL8 (0.50) CXCL8ACP3GLSADRB2ADRB1
SCHEMBL16023820 0.88 CXCL8 (0.50) CXCL8ACP3GLSADRB2ADRB1
SCHEMBL27603271 0.85 CXCL8 (0.47) CXCL8ACP3GLSADRB2ADRB1
SCHEMBL2204495 0.84 PTGS2 (0.56) CXCL8PTGS2MMP1MMP2MMP9
SCHEMBL15568192 0.84 CXCL8 (0.59) CXCL8PTGS2MMP1MMP2MMP9
SCHEMBL15568736 0.84 CXCL8 (0.59) CXCL8PTGS2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116987034-A 5- ((4-chloro-2, 3-dihydro-1H-inden-1-yl) methyl) -1H-imidazole and synthetic method thereof 安徽大学 2023-11-03 CN claimed
US-20160168306-A1 NOVEL COMPOSITIONS AND METHODS TO PRODUCE TRIAZINE-ARYLHYDROXY-ALDEHYDE CONDENSATES WITH IMPROVED SOLUBILITY WILMINGTON SAVINGS FUND SOCIETY, FSB, AS THE CURRENT COLLATERAL AGENT 2016-06-16 US claimed
EP-1354906-B1 Polyamide resin MITSUBISHI GAS CHEMICAL CO (JP) 2012-12-05 EP claimed
US-7012138-B1 Chiral polysaccharide esters, one of the methods for preparing them and their uses for obtaining optically enriched acids or for chiral chromatography UNIVERSITE DE DROIT D'ECONOMIE ET DES SCIENCES D'AIZ-MARSEILLE (FR) 2006-03-14 US claimed
US-6903119-B1 Amino acid derivatives and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-06-07 US claimed
US-6841651-B2 Polyamide resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2005-01-11 US claimed
US-20030199667-A1 Polyamide resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2003-10-23 US claimed
EP-1354906-A1 Polyamide resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2003-10-22 EP claimed
EP-1135417-B1 POLYSACCHARIDE CHIRAL ESTERS, ONE OF THE METHODS FOR PREPARING THEM AND THEIR USES FOR OBTAINING OPTICALLY ENRICHED ACIDS OR CHIRAL CHROMATOGRAPHY UNIV DROIT D ECONOMIE ET DES S (FR) 2003-06-25 EP claimed
EP-1135417-A1 POLYSACCHARIDE CHIRAL ESTERS, ONE OF THE METHODS FOR PREPARING THEM AND THEIR USES FOR OBTAINING OPTICALLY ENRICHED ACIDS OR CHIRAL CHROMATOGRAPHY Universite De Droit, D'Economie et des Sciences D'Aix-Marseille (FR) 2001-09-26 EP claimed
WO-2000032638-A1 POLYSACCHARIDE CHIRAL ESTERS, ONE OF THE METHODS FOR PREPARING THEM AND THEIR USES FOR OBTAINING OPTICALLY ENRICHED ACIDS OR CHIRAL CHROMATOGRAPHY UNIVERSITE DE DROIT, D'ECONOMIE ET DES SCIENCES D'AIX-MARSEILLE (FR) 2000-06-08 WO claimed
CN-116396257-B Dihydrocoumarin Process for the preparation of compounds 河南中烟工业有限责任公司 2025-06-10 CN disclosed
WO-2025074305-A1 N-(1-(AMINOMETHYL)CYCLOPROPYL)(ARYL OR HETEROARYL) CARBOXAMIDE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2025-04-10 WO disclosed
US-20240024490-A1 BIFUNCTIONAL MOLECULES FOR SELECTIVE MODIFICATION OF TARGET SUBSTRATES THE BROAD INSTITUTE, INC. 2024-01-25 US disclosed
CN-116987034-A 5- ((4-chloro-2, 3-dihydro-1H-inden-1-yl) methyl) -1H-imidazole and synthetic method thereof 安徽大学 2023-11-03 CN disclosed
US-5536874-A Process for preparing arylacetic acid and arylpropionic acid derivatives HOECHST CELANESE CORPORATION (US) 1996-07-16 US disclosed
EP-0098058-B1 SYNTHESIS OF PHENYLACETIC ACID ESTERS ELI LILLY AND COMPANY (US) 1986-02-19 EP disclosed
EP-0056144-A1 Carboxylic acid derivatives, their preparation and use as pharmaceuticals Dr. Karl Thomae GmbH (DE) 1982-07-21 EP disclosed
US-4153707-A Fungicidal isoxazolyl phenols and method of use THE UPJOHN COMPANY (US) 1979-05-08 US disclosed
US-4065574-A New method for controlling fungi using 4-chromone, 4-chromanone, 4-chromone oxime and 4-chromanone oxime compounds THE UPJOHN COMPANY (US) 1977-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240024490-A1 BIFUNCTIONAL MOLECULES FOR SELECTIVE MODIFICATION OF TARGET SUBSTRATES COASY, JMJD7, PTMS CXCL8 4855/4885PTGS2 3394/4885MMP1 3979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.